Citadel Advisors’s Pasithea Therapeutics KTTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$33.8K Buy
+46,858
New +$33.8K ﹤0.01% 5547
2023
Q2
Sell
-1,253
Closed -$9.75K 6174
2023
Q1
$9.75K Buy
+1,253
New +$9.75K ﹤0.01% 5522
2022
Q2
Sell
-3,647
Closed -$95K 6522
2022
Q1
$95K Buy
+3,647
New +$95K ﹤0.01% 5679